Potential Therapeutic Targets for Oral Cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70

por Bundela, Saurabh, Sharma, Anjana, Bisen, Prakash S.
Publicado 2014

Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine

por Bundela, Saurabh, Sharma, Anjana, Bisen, Prakash S.
Publicado 2015

Diagnosis and Monitoring of Infections

por Debnath, Mousumi, Prasad, Godavarthi B.K.S., Bisen, Prakash S.
Publicado 2009

Molecular Microbiological Testing

por Debnath, Mousumi, Prasad, Godavarthi B.K.S., Bisen, Prakash S.
Publicado 2009

Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma

por Khan, Zakir, Khan, Abdul Arif, Yadav, Hariom, Prasad, Godavarthi B. K. S., Bisen, Prakash Singh
Publicado 2017

Genetic affinities between endogamous and inbreeding populations of Uttar Pradesh

por Khan, Faisal, Pandey, Atul Kumar, Tripathi, Manorma, Talwar, Sudha, Bisen, Prakash S, Borkar, Minal, Agrawal, Suraksha
Publicado 2007

Prevalence of Metabolic Syndrome in Type 2 Diabetes Mellitus Using NCEP-ATPIII, IDF and WHO Definition and Its Agreement in Gwalior Chambal Region of Central India

por Yadav, Dhananjay, Mahajan, Sunil, Subramanian, Senthil K., Bisen, Prakash Singh, Chung, Choon Hee, Prasad, GBKS
Publicado 2013

Prevalence of Dyslipidemia and Hypertension in Indian Type 2 Diabetic Patients with Metabolic Syndrome and its Clinical Significance

por Yadav, Dhananjay, Mishra, Meerambika, Tiwari, Arvind, Bisen, Prakash Singh, Goswamy, Hari Mohan, Prasad, G.B.K.S.
Publicado 2014